Tetratherix (ASX:TTX) has announced a significant step forward for its US-based joint venture BioOptix, with the ophthalmic biomaterials company signing a development agreement with global eye-care leader Alcon Research.
Tetratherix joint venture secures Alcon partnership to accelerate ophthalmic biomaterials
December 1, 2025 Australian Biotech
Latest Video
New Stories
-
Pharmac to expand emergency medicine access for rural and remote communities
December 1, 2025 - - Latest News -
Tetratherix joint venture secures Alcon partnership to accelerate ophthalmic biomaterials
December 1, 2025 - - Australian Biotech -
MSD to bring vaccine distribution back in-house after 40-year partnership
December 1, 2025 - - Latest News -
New PBS listing offers fresh hope for Australians living with debilitating skin condition
December 1, 2025 - - Latest News -
Five Australians honoured for leadership and community advocacy in evolving HIV response
December 1, 2025 - - Latest News -
Budget discipline tightens with agencies directed to target 'lowest priority work'
November 30, 2025 - - Latest News -
The 'Dispatched' Podcast - 30 November
November 30, 2025 - - Podcast
